Effect of Urate-Lowering Therapy on the Progression of Kidney Function in Patients With Asymptomatic Hyperuricemia: A Systematic Review and Meta-Analysis. [PDF]
Zhang L +5 more
europepmc +1 more source
Non-adherence to urate lowering therapy in gout after 5 years is related to poor outcomes: results from the NOR-Gout study. [PDF]
Uhlig T +6 more
europepmc +1 more source
Xanthine oxidase inhibitor urate-lowering therapy titration to target decreases serum free fatty acids in gout and suppresses lipolysis by adipocytes. [PDF]
Guma M +11 more
europepmc +1 more source
Implementing treat-to-target urate-lowering therapy during hospitalizations for gout flares. [PDF]
Russell MD +22 more
europepmc +1 more source
Depressive Symptoms and the Effectiveness of a Urate-Lowering Therapy in a Clinical Trial. [PDF]
Mrug S +6 more
europepmc +1 more source
Effectiveness of Urate-Lowering Therapy for Renal Function in Patients With Chronic Kidney Disease: A Meta-Analysis of Randomized Clinical Trials. [PDF]
Liang X, Liu X, Li D, Qin W, Liu Y.
europepmc +1 more source
Quantitative Assessment of Baseline Serum HDL-C to Predict Gout Flares During Urate-Lowering Therapy Initiation: A Prospective Cohort Study. [PDF]
Jiang C +10 more
europepmc +1 more source
Correction to "Gout Remission With Pegloticase-Induced Intensive Urate-Lowering Therapy: A Post Hoc Clinical Trial Analysis". [PDF]
europepmc +1 more source
Baseline Dual-Energy Computed Tomography Urate Volume Predicts Fulfillment of Gout Remission After Two Years of Urate-Lowering Therapy. [PDF]
Tabi-Amponsah AD +10 more
europepmc +1 more source
Effective xanthine oxidase inhibitor urate lowering therapy in gout is linked to an emergent serum protein interactome of complement and inflammation modulators. [PDF]
Sanchez C +6 more
europepmc +1 more source

